PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference

Financial Results Announcement - PROCEPT BioRobotics will report financial results for the fourth quarter of 2024 after market close on February 25, 2025 [1] - A conference call will be hosted by the Company's management at 4:30 p.m. Eastern Time on the same day [1] Conference Presentations - Management will present at the TD Cowen 45th Annual Healthcare Conference on March 4 at 1:10 p.m. Eastern Time [3] - Additionally, management will present at the 2025 Leerink Partners Healthcare Conference on March 11 at 3:00 p.m. Eastern Time [3] Company Overview - PROCEPT BioRobotics focuses on advancing patient care through surgical robotics, specifically in urology [5] - The Company manufactures the AQUABEAM and HYDROS™ Robotic Systems, with the HYDROS system being the only AI-powered technology delivering Aquablation therapy [5] - Aquablation therapy is designed for effective treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH), affecting approximately 40 million men in the U.S. [5] - The Company has over 150 peer-reviewed publications supporting the clinical advantages of Aquablation therapy [5]